Eli Lilly invests in AI-designed drugs in new deal with Insilico Medicine worth up to €2.39bn 😊
Euronews.com
1 napja
😊
Cikk tartalma röviden
Eli Lilly and Insilico Medicine have entered a $2.75 billion deal for AI-driven drug discovery, utilizing Insilico's AI platform to develop new therapeutics. The partnership aims to address high unmet medical needs and enhance drug discovery processes.Kulcsszavak
Személyek
pozitív, negatív, semleges szavak
transformative
powerful
novel
exclusive
new
clinical-stage